MedTrace Logo

Skin Manifestations Associated With Adhesives in Diabetes Technology Tools

NCT04853810 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 851

Last updated 2024-01-03

No results posted yet for this study

Summary

The use of technological tools in the treatment of diabetes has intensified and become common in recent years. Many of these systems adhere to the skin with an adhesive in place between 2 and 14 days. The objective of this study is to determine the prevalence and consequences of skin reactions to skin adhesive systems for the treatment of diabetes.

Conditions

Interventions

OTHER

CUTADIAB questionnaire

During a regular diabetes follow-up consultation, the patient is asked to complete the CUTADIAB questionnaire on a tablet, entirely dedicated to the study

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Agnès SOLA GAZAGNES, MD · AP-HP, Cochin Hospital, Department of Diabetology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2021-11-17
Completion
2021-11-17

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04853810 on ClinicalTrials.gov